Literature DB >> 30266560

Visualizing bioactive ceramides.

Daniel Canals1, Silvia Salamone2, Yusuf A Hannun2.   

Abstract

In the last 30 years, ceramides have been found to mediate a myriad of biological processes. Ceramides have been recognized as bioactive molecules and their metabolizing enzymes are attractive targets in cancer therapy and other diseases. The molecular mechanism of action of cellular ceramides are still not fully established, with insights into roles through modification of lipid rafts, creation of ceramide platforms, ceramide channels, or through regulation of direct protein effectors such as protein phosphatases and kinases. Recently, the 'Many Ceramides' hypothesis focuses on distinct pools of subcellular ceramides and ceramide species as potential defined bioactive entities. Traditional methods that measure changes in ceramide levels in the whole cell, such as mass spectrometry, fluorescent ceramide analogues, and ceramide antibodies, fail to differentiate specific bioactive species at the subcellular level. However, a few ceramide binding proteins have been reported, and a smaller subgroup within these, have been shown to translocate to ceramide-enriched membranes, revealing these localized pools of bioactive ceramides. In this review we want to discuss and consolidate these works and explore the possibility of defining these binding proteins as new tools are emerging to visualize bioactive ceramides in cells. Our goal is to encourage the scientific community to explore these ceramide partners, to improve techniques to refine the list of these binding partners, making possible the identification of specific domains that recognize and bind ceramides to be used to visualize the 'Many Ceramides' in the cell.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30266560      PMCID: PMC6233321          DOI: 10.1016/j.chemphyslip.2018.09.013

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  104 in total

1.  Streptolysin O-permeabilized granulocytes shed L-selectin concomitantly with ceramide generation via neutral sphingomyelinase.

Authors:  I Walev; D Tappe; E Gulbins; S Bhakdi
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

2.  Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis.

Authors:  H Birbes; S El Bawab; Y A Hannun; L M Obeid
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

Review 3.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

4.  Kinase suppressor of Ras is ceramide-activated protein kinase.

Authors:  Y Zhang; B Yao; S Delikat; S Bayoumy; X H Lin; S Basu; M McGinley; P Y Chan-Hui; H Lichenstein; R Kolesnick
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

5.  Characterization of bacterial phospholipids by electrospray ionization tandem mass spectrometry.

Authors:  P B Smith; A P Snyder; C S Harden
Journal:  Anal Chem       Date:  1995-06-01       Impact factor: 6.986

6.  Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells.

Authors:  Guanghu Wang; Jeane Silva; Kannan Krishnamurthy; Eric Tran; Brian G Condie; Erhard Bieberich
Journal:  J Biol Chem       Date:  2005-05-18       Impact factor: 5.157

7.  Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A.

Authors:  P P Ruvolo; X Deng; T Ito; B K Carr; W S May
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis.

Authors:  H Sawai; T Okazaki; Y Takeda; M Tashima; H Sawada; M Okuma; S Kishi; H Umehara; N Domae
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

9.  Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets.

Authors:  Y A Hannun; C R Loomis; A H Merrill; R M Bell
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

10.  Overexpression of ceramide synthase 1 increases C18-ceramide and leads to lethal autophagy in human glioma.

Authors:  Zheng Wang; Lijun Wen; Fei Zhu; Yanping Wang; Qing Xie; Zijun Chen; Yunsen Li
Journal:  Oncotarget       Date:  2017-10-23
View more
  13 in total

1.  Ceramide regulates interaction of Hsd17b4 with Pex5 and function of peroxisomes.

Authors:  Zhihui Zhu; Jianzhong Chen; Guanghu Wang; Ahmed Elsherbini; Liansheng Zhong; Xue Jiang; Haiyan Qin; Priyanka Tripathi; Wenbo Zhi; Stefka D Spassieva; Andrew J Morris; Erhard Bieberich
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-06-05       Impact factor: 4.698

Review 2.  Advances in determining signaling mechanisms of ceramide and role in disease.

Authors:  Jeffrey L Stith; Fabiola N Velazquez; Lina M Obeid
Journal:  J Lipid Res       Date:  2019-03-07       Impact factor: 5.922

3.  Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy.

Authors:  Daniel Canals; Silvia Salamone; Bruno Jaime Santacreu; Erika Nemeth; Daniel Aguilar; María José Hernandez-Corbacho; Mohamad Adada; Daniela I Staquicini; Wadih Arap; Renata Pasqualini; John Haley; Lina M Obeid; Yusuf A Hannun
Journal:  FASEB J       Date:  2020-04-20       Impact factor: 5.191

4.  Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.

Authors:  Wataru Sakamoto; Daniel Canals; Silvia Salamone; Janet Allopenna; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2019-06-26       Impact factor: 5.922

5.  The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha.

Authors:  Daniel Canals; Silvia Salamone; Bruno Jaime Santacreu; Daniel Aguilar; María José Hernandez-Corbacho; Anne G Ostermeyer-Fay; Meaghan Greene; Erika Nemeth; John D Haley; Lina M Obeid; Yusuf A Hannun
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

Review 6.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

Review 7.  Very long-chain saturated fatty acids and diabetes and cardiovascular disease.

Authors:  Rozenn N Lemaitre; Irena B King
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.616

Review 8.  Ceramides and Sphingosino-1-Phosphate in Obesity.

Authors:  Ilona Juchnicka; Mariusz Kuźmicki; Jacek Szamatowicz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-13       Impact factor: 5.555

9.  Antibacterial and cytotoxic activities of new sphingolipids and other constituents isolated from Cissus incisa leaves.

Authors:  Deyani Nocedo-Mena; Verónica M Rivas-Galindo; Patricia Navarro; Elvira Garza-González; Leticia González-Maya; María Yolanda Ríos; Abraham García; Francisco G Ávalos-Alanís; José Rodríguez-Rodríguez; María Del Rayo Camacho-Corona
Journal:  Heliyon       Date:  2020-08-29

10.  Microglia modulate stable wakefulness via the thalamic reticular nucleus in mice.

Authors:  Hanxiao Liu; Xinxing Wang; Lu Chen; Liang Chen; Stella E Tsirka; Shaoyu Ge; Qiaojie Xiong
Journal:  Nat Commun       Date:  2021-07-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.